Roderick de Greef

Chief Executive Officer & Chairman, BIOLIFE SOLUTIONS INC

Search every verified Roderick de Greef interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Roderick De greef, Chief Financial Officer of BioLife Solutions, participated in the company’s Q2 2021 earnings call on August 12, 2021, where he opened the presentation and discussed the company’s financial results and operational highlights for the three and six months ended June 30, 2021. During the call, he addressed forward-looking statements and noted that the company had increased its guidance range by the expected contribution from the Sexton acquisition, while leaving the existing range unchanged due to seasonality in the freezer business for Q3 and Q4. De greef also engaged in the Q&A session, where he and other executives fielded questions from analysts on topics such as the use of vials versus bags in cell therapy and the company’s product pipeline. In the transcript, he is identified as the Chief Financial Officer, while Michael Rice is listed as Chief Executive Officer and Chairman, and Dusty Tenney as President and Chief Operating Officer. The selected quote attributed to De greef in the source material appears to reference NVIDIA’s Vera CPU and a $200 billion total addressable market, but this statement is not consistent with the context of the BioLife earnings call and may be from a different source.